Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODIFIED: JRecanTM Device + IV r-tPA in Acute Ischemic Stroke
NCT02347358Phase 2Unknown
- Sponsor
- PLA Rocket Force Characteristic Medical Center
- Start
- Feb 2015
- Primary completion
- Jan 2017
01
Overview
Phase 2, randomised, open-label trial in ischemic stroke (2 arms), sponsored by PLA Rocket Force Characteristic Medical Center. Primary endpoint: Early successful recanalisation at 24 hours. Status: unknown.
02
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02347358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347358.